Demo Data from EDBT 2026 / reviewers in the wild / expert
Olga A. Tarasova
dblp:166/7586
· DBLP profile ↗
1ranked-venue papers
0as first author
1since 2021 · last 2022
0000-0002-3723-7832ORCID · reported
Domains — the database's venue-derived domains; a paper can count in several
Applied, interdisciplinary, general and emerging computing · 1 · 1 since 2021
Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.
| Interdisciplinary, comprehensive, and emerging computing
1 paper |
Bioinformatics and computational biology · 100% |
Topics — the 3 heaviest of 4, each with the papers that count most for it
| Topic | Weight | Papers | Last | Evidence papers |
|---|---|---|---|---|
Bioinformatics and computational biology › computational microbiology
drug resistance prediction |
0.6 | 1 | 2022 | HIV-1 drug resistance profiling using amino acid sequence space cartography · Bioinform. 2022 |
Bioinformatics and computational biology › statistical genetics
genotype-phenotype analysis |
0.6 | 1 | 2022 | HIV-1 drug resistance profiling using amino acid sequence space cartography · Bioinform. 2022 |
Bioinformatics and computational biology › clinical bioinformatics
HIV drug resistance |
0.6 | 1 | 2022 | HIV-1 drug resistance profiling using amino acid sequence space cartography · Bioinform. 2022 |
Methods — techniques the papers use, named apart from their topics
generative topographic mapping · 0.6
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2022 | HIV-1 drug resistance profiling using amino acid sequence space cartographyabstractMOTIVATION: Human immunodeficiency virus (HIV) drug resistance is a global healthcare issue. The emergence of drug resistance influenced the efficacy of treatment regimens, thus stressing the importance of treatment adaptation. Computational methods predicting the drug resistance profile from genomic data of HIV isolates are advantageous for monitoring drug resistance in patients. However, existing computational methods for drug resistance prediction are either not suitable for emerging HIV strains with complex mutational patterns or lack interpretability, which is of paramount importance in clinical practice. The approach reported here overcomes these limitations and combines high accuracy of predictions and interpretability of the models. RESULTS: In this work, a new methodology based on generative topographic mapping (GTM) for biological sequence space representation and quantitative genotype-phenotype relationships prediction purposes was introduced. The GTM-based resistance landscapes allowed us to predict the resistance of HIV strains based on sequencing and drug resistance data for three viral proteins [integrase (IN), protease (PR) and reverse transcriptase (RT)] from Stanford HIV drug resistance database. The average balanced accuracy for PR inhibitors was 0.89 ± 0.01, for IN inhibitors 0.85 ± 0.01, for non-nucleoside RT inhibitors 0.73 ± 0.01 and for nucleoside RT inhibitors 0.84 ± 0.01. We have demonstrated in several case studies that GTM-based resistance landscapes are useful for visualization and analysis of sequence space as well as for treatment optimization purposes. Here, GTMs were applied for the in-depth analysis of the relationships between mutation pattern and drug resistance using mutation landscapes. This allowed us to predict retrospectively the importance of the presence of particular mutations (e.g. V32I, L10F and L33F in HIV PR) for the resistance development. This study highlights some perspectives of GTM applications in clinical informatics and particularly in the field of sequence space exploration. AVAILABILITY AND IMPLEMENTATION: https://github.com/karinapikalyova/ISIDASeq. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online. Karina Pikalyova, Alexey Orlov, Arkadii I. Lin, Olga A. Tarasova, Gilles Marcou, Dragos Horvath, Vladimir Poroikov, Alexandre Varnek |
Bioinform. | 4 |